The 13th Annual Personalized Medicine Conference will define the landscape, outlook and next steps for personalized medicine in science, business and policy.
November 14 - 16, 2017
Joseph B. Martin Conference Center
Harvard Medical School
The 13th Annual Personalized Medicine Conference was organized by a cross-industry, cross-disciplinary panel, made up of 38 providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of the field.
Edward Abrahams, Ph.D.
President, Personalized Medicine Coalition
Amy Abernethy, M.D., Ph.D.
Chief Medical Officer, Chief Scientific Officer, Senior Vice President, Oncology, Flatiron Health
Bonnie J. Addario
Founder, Chair, Bonnie J. Addario Lung Cancer Foundation, Founder, Addario Lung Cancer Medical Institute
Founder, Principal, The Bethesda Group LLC
Steven D. Averbuch, M.D.
Vice President, Development, Oncology & Pharmacodiagnostics, Bristol-Myers Squibb Company
Suzanne Belinson, Ph.D., M.P.H.
Executive Director, Center for Clinical Effectiveness, Blue Cross Blue Shield Association
William Chin, M.D.
Chief Medical Officer, Executive Vice President,Science & Regulatory Advocacy, PhRMA
Senior Vice President, Feinstein Kean Healthcare | An Ogilvy Company
Donna Cryer, J.D.
President & CEO, Global Liver Institute
William S. Dalton, Ph.D., M.D.
CEO, M2Gen; Director, The DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center
George Demetri, M.D.
Director, Center for Sarcoma and Bone Oncology, Senior Vice President, Experimental Therapeutics, Institute Physician, Dana-Farber Cancer Institute; AACR Representative
Stephen L. Eck, M.D., Ph.D.
President, CEO, Aravive Biologics; Board Chairman, Personalized Medicine Coalition
Margaret Foti, Ph.D., M.D. (h.c.)
CEO, American Association for Cancer Research
Kathy Giusti, M.B.A.
Founder, Multiple Myeloma Research Foundation
Robert C. Green, M.D., M.P.H.
Director, G2P Research Program, Associate Director for Research, Partners Personalized Medicine, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Broad Institute and Harvard Medical School
Richard Hamermesh, D.B.A.
Faculty Co-Chair, Kraft Precision Medicine Accelerator, Senior Fellow, Former MBA Class of 1961, Professor of Management Practice, Harvard Business School
Trevor Hawkins, Ph.D.
Entrepreneur-in-Residence, GE Ventures
Robert Huckman, Ph.D.
Albert J. Weatherhead III Professor of Business Administration, Faculty Co-Chair, Health Care Initiative, Harvard Business School
Patrick James, M.D.
Chief Clinical Officer, Health Plans and Policy, Medical Affairs, Quest Diagnostics
Marcia A. Kean, M.B.A.
Chairman, Strategic Initiatives, Feinstein Kean Healthcare | An Ogilvy Company
Jeffrey A. Leerink
Founder, Chairman, CEO, Leerink Partners
Partner, Third Rock Ventures
Founder, Publisher, Genome magazine
Founder, Managing Partner, GreyBird Ventures
Cynthia Morton, Ph.D.
William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology, Professor of Pathology, Harvard Medical School; Director of Cytogenetics, Brigham and Women’s Hospital
Lincoln Nadauld, M.D., Ph.D.
Executive Director, Precision Medicine and Precision Genomics, Intermountain Healthcare
Michael Pellini, M.D.
Chairman, Foundation Medicine
Chairman, Chief Executive Officer, President, Genomic Health
Daryl Pritchard, Ph.D.
Vice President, Science Policy, Personalized Medicine Coalition
Jon Retzlaff, M.B.A., M.P.A.
Chief Policy Officer, Vice President, Science Policy and Government Affairs, Office of Science Policy and Government Affairs, American Association for Cancer Research
Steven Rosen, Ph.D.
Senior Director, Diagnostic Strategy, Novartis Pharmaceuticals
Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Enterprise Scientific Technology Operations, Worldwide R & D, Pfizer
Kenna Shaw, Ph.D
Executive Director, Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (IPCT), MD Anderson Cancer Center
Michael Sherman, M.D., M.B.A., M.S.
Senior Vice President, Chief Medical Officer, Harvard Pilgrim Health Care
Ralph Snyderman, M.D.
James B. Duke Professor of Medicine, Duke University Medical Center
Katherine Johansen Taber, Ph.D.
Director, Personalized Medicine, American Medical Association
Alex Vadas, Ph.D
Managing Director, Partner, L.E.K. Consulting
Jay Wohlgemuth, M.D.
Senior Vice President, R & D, Medical, Chief Medical Officer, Quest Diagnostics